China User Group Meeting
18 October 2023
China User Group Meeting Read More »
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer
An interview with Jonathon Bartlett, Chief Human Resources Officer – Indica Labs
An interview with Jonathon Bartlett, Chief Human Resources Officer – Indica Labs Read More »
12 October 2023 | Please join us for this 1-hour webinar to learn about characterizing cell heterogeneity with HALO to gain new biological insights.
28 September 2023 | Please join us for this 1-hour webinar to learn about the exciting new features of our AI-powered, pathologist-driven digital pathology platform, HALO AP, and our Breast IHC AI suite
Sneak Peek: HALO AP® 2.2 and Breast IHC AI Read More »
21 September 2023 | This presentation will illustrate a suite of tools developed by our group utilizing the GraphQL framework to streamline existing workflows within Novartis and begin to integrate pathology-based tools from across the organization into the HALO environment.
7 September 2023 | Please join us for this 1-hour webinar to review tips and tricks for building a HALO AI classifier.
Masterclass Webinar: Tips and Tricks for Building a HALO AI Classifier Read More »
In this blog post we will discuss the basics of cloud computing, benefits and considerations of cloud vs. traditional deployments, and how our Professional Services team can help you optimize your cloud deployment.
Taking HALO® to the Cloud with Indica Labs Cloud Services Read More »
Indica Labs’ Pharma Services is a growing team of experienced image analysts and imaging scientists with backgrounds in digital pathology, immuno-oncology, cancer biology, neuroscience, bioinformatics, and data science.
Finding the Right Expertise and Tools with Indica Labs’ Pharma Services Read More »
Albuquerque, NM, – 26 June 2023 – Indica Labs, a leading provider of computational pathology software, is delighted to announce that they have been awarded a Top Workplaces™ honor by The Albuquerque Journal for the fourth year in a row.